ORCHPHARMA.NSORCHPHARMA.NSNSE

Revenue (LTM)

$9.2B

+12.6% YoY

Net Income (LTM)

$997M

+8.1% YoY

Free Cash Flow

$-1.3B

Revenue CAGR (5Y)

+13.8%

Marginsdeclining

FCFTurned negative

Profitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	4,501	5,596↑24.3%	6,659↑19.0%	8,191↑23.0%	9,219↑12.6%
Gross Profit	2,088	2,325↑11.4%	707↓69.6%	1,362↑92.6%	3,548↑160.6%
Operating Income	-505	-339↑32.9%	297↑187.5%	777↑161.9%	811↑4.4%
Net Income	-1,165	-20↑98.3%	463↑2473.8%	922↑99.0%	997↑8.1%
EBITDA	650	621↓4.4%	1,429↑130.0%	1,419↓0.7%	1,447↑1.9%
EPS Diluted	-28.55	-0.48↑98.3%	11.35↑2464.6%	19.06↑67.9%	19.65↑3.1%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	157	43↓72.6%	226↑424.7%	36↓84.1%	211↑486.2%
Total Current Assets	5,499	3,976↓27.7%	5,010↑26.0%	7,908↑57.8%	8,074↑2.1%
Total Assets	12,373	11,106↓10.2%	12,252↑10.3%	15,539↑26.8%	16,879↑8.6%
Total Current Liabilities	1,421	2,408↑69.5%	3,719↑54.5%	2,600↓30.1%	2,856↑9.8%
Total Liabilities	5,843	4,632↓20.7%	5,366↑15.8%	3,844↓28.4%	4,206↑9.4%
Total Equity	6,529	6,474↓0.8%	6,886↑6.4%	11,695↑69.8%	12,673↑8.4%
Total Debt	4,527	2,680↓40.8%	3,313↑23.7%	1,352↓59.2%	1,746↑29.2%
Net Debt	4,370	2,636↓39.7%	3,087↑17.1%	1,316↓57.4%	1,535↑16.7%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	236	925↑292.1%	183↓80.2%	1,260↑587.1%	192↓84.7%
Capital Expenditure	-6	-144↓2284.7%	-849↓489.5%	-648↑23.7%	-1,501↓131.6%
Free Cash Flow	230	781↑239.7%	-666↓185.3%	612↑191.9%	-1,309↓314.0%
Stock-Based Comp	0	0	0	0	0
Net Change in Cash	-742	-114↑84.7%	183↑260.6%	-190↓203.9%	175↑192.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance